FDA Approves Drug for Advanced Thyroid Cancer

February 13, 2015 9:00 PM

3 0

FRIDAY, Feb. 13, 2015 (HealthDay News) -- The U.S. Food and Drug Administration on Friday approved a new drug to treat progressive thyroid cancer that continues to worsen despite radioactive iodine therapy.

Results of a just-published clinical trial found that the oral drug Lenvima (lenvatinib) delayed progression of the disease almost five times longer than a placebo in people with recurring tumors.

Also read: Intel reports better-than-expected earnings as data center chips grow 13% to $4.5 billion

Read more

To category page